STOCKSCOPE

ASX Rebounds as Fed Holds Rates, but China and Inflation Keep Markets on Edge

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:29 Oct 2026
ASX Rebounds as Fed Holds Rates, but China and Inflation Keep Markets on Edge

Australian shares advanced on Thursday, 29 October, with the ASX 200 gaining approximately 0.5% to reach a one-month high, supported by financials, real estate investment trusts and energy stocks. However, market breadth was less convincing, with 509 stocks declining against 483 advancing and 348 unchanged. The uneven participation suggests the rebound was not a broad-based vote of confidence.

Mesoblast (ASX: MSB) surged 22.87% to AUD 2.31, while IperionX (ASX: IPX) climbed 15.71% to AUD 2.43 and Neuren Pharmaceuticals (ASX: NEU) gained 6.39%. At the other end, Champion Iron (ASX: CIA) plunged 16.59%, while PLS Group (ASX: PLS) fell 7.53% and Liontown Resources (ASX: LTR) lost 4.61%. The weakness in lithium and iron ore-related shares highlights continuing pressure on parts of the resources sector, despite firmer sentiment elsewhere.

The key question is whether financials and income-sensitive sectors can sustain the recovery while elevated borrowing costs and uncertainty around Chinese demand weigh on cyclical businesses.

The Australian dollar, bonds and the RBA

Australia's inflation outlook has become more difficult. Annual CPI inflation accelerated to 4.3% in September from 4.0% in August, while trimmed mean inflation increased to 3.6%. With the cash rate at 4.60%, the Reserve Bank of Australia has little room to ease policy while underlying price pressures remain elevated.

The Australian dollar was around USD 0.703 at the latest official observation on Wednesday. Higher domestic inflation could support the currency through expectations of tighter monetary policy, although a stronger US dollar or weaker Chinese demand could offset that effect. For property and growth stocks, persistently high rates remain a valuation headwind.

Global markets: China, Asia and Europe

Chinese equities weakened on Thursday, with the Shanghai Composite falling 0.93% to 3,647.12. The decline reinforces concerns about the durability of the region's recovery, although one session cannot establish a broader trend. For Australian miners, sustained improvement in Chinese construction, steel demand and industrial activity matters more than short-term movements in equity indices.

We should distinguish policy announcements from tangible improvements in demand. Without stronger evidence of industrial activity and property stabilisation, expectations for iron ore and base metals remain vulnerable. European market developments were less decisive for the immediate Australian outlook than the combination of Chinese demand and US monetary policy.

Wall Street: US stocks and the Federal Reserve

Wall Street finished Wednesday modestly higher after the Federal Reserve held its benchmark rate at 3.75% to 4.00%. The S&P 500 gained 0.28% to 7,743.98, the Nasdaq Composite rose 0.27% to 26,549.85 and the Dow Jones Industrial Average added 0.19% to 52,475.10.

The decision was not entirely reassuring. Two policymakers dissented in favour of a 0.25 percentage-point increase, while the Fed described economic activity as strong and inflation as elevated. The combination suggests that further tightening remains possible if price pressures persist.

US Treasury yields reflected the uncertainty. The two-year yield fell to around 4.70%, while the 10-year yield approached 5.00%. This divergence points to different expectations for near-term policy and longer-term borrowing costs. For Australian equities, the risk is that resilient US growth supports earnings but elevated yields constrain valuations.

Commodities: gold, oil and industrial metals

Gold futures traded near USD 4,053 an ounce, little changed in the latest reported session. Gold continues to face competing forces: geopolitical uncertainty and demand for defensive assets support prices, while elevated yields increase the opportunity cost of holding a non-yielding asset.

Oil was more clearly under pressure. December US crude futures fell 1.53% to USD 101.21 a barrel, while January Brent futures declined 1.46% to USD 110.01. These remain elevated levels, but the daily retreat could ease some cost pressure if sustained. For Australian energy producers, the effect will depend on realised prices, production volumes and operating costs.

What to watch next

The immediate focus is Australia's inflation trajectory and the RBA's next decision on 3 November. Markets will also assess whether Chinese equities and commodity demand stabilise, while US economic releases could shift expectations for another rate increase in December.

Our assessment is cautiously constructive on the ASX rebound, but not yet convinced that it signals a durable improvement. Stronger participation across sectors would improve the outlook; persistent inflation, rising long-term yields or renewed weakness in Chinese demand would challenge it.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...